Αlpha Beta (α/β) T cell Depleted Second HCT Is Effective for Impending Secondary Graft Failure after Reduced Intensity and Nonmyeloablative MSD HCT in Sickle Cell Disease

Key Points

• Second hematopoietic cell transplantation effectively addresses impending graft failure in sickle cell disease.
• Primary outcome showed successful prevention of graft failure using alpha beta T cell depletion in patients.
• Analysis of hematopoietic cell transplantation records highlights reduced intensity and nonmyeloablative methods.
• Supports the potential of this treatment approach, but further studies are necessary to validate findings.